Literature DB >> 19635955

Species identification and antifungal susceptibility patterns of species belonging to Aspergillus section Nigri.

Laura Alcazar-Fuoli1, Emilia Mellado, Ana Alastruey-Izquierdo, Manuel Cuenca-Estrella, Juan L Rodriguez-Tudela.   

Abstract

A phylogenetic analysis was performed for 34 Aspergillus strains belonging to section Nigri. Molecular methods allowed for the correct classification into three different clades (A. niger, A. tubingensis, and A. foetidus). Correlation with in vitro itraconazole susceptibility distinguished the following three profiles: susceptible, resistant, and showing a paradoxical effect. A number of different species whose morphological features resemble those of A. niger showed unusual MICs to itraconazole that have never been described for the Aspergillus genus.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19635955      PMCID: PMC2764190          DOI: 10.1128/AAC.00585-09

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  16 in total

Review 1.  Sequence-based identification of Aspergillus, fusarium, and mucorales species in the clinical mycology laboratory: where are we and where should we go from here?

Authors:  S A Balajee; A M Borman; M E Brandt; J Cano; M Cuenca-Estrella; E Dannaoui; J Guarro; G Haase; C C Kibbler; W Meyer; K O'Donnell; C A Petti; J L Rodriguez-Tudela; D Sutton; A Velegraki; B L Wickes
Journal:  J Clin Microbiol       Date:  2008-12-10       Impact factor: 5.948

2.  Report on a case of subcutaneous dissemination of Aspergillus niger, type awamori.

Authors:  H Paldrok
Journal:  Acta Derm Venereol       Date:  1965       Impact factor: 4.437

3.  Assessment of the paradoxical effect of caspofungin in therapy of candidiasis.

Authors:  Karl V Clemons; Marife Espiritu; Rachana Parmar; David A Stevens
Journal:  Antimicrob Agents Chemother       Date:  2006-04       Impact factor: 5.191

4.  Studies of the paradoxical effect of caspofungin at high drug concentrations.

Authors:  David A Stevens; Theodore C White; David S Perlin; Claude P Selitrennikoff
Journal:  Diagn Microbiol Infect Dis       Date:  2005-03       Impact factor: 2.803

5.  Mistaken identity: Neosartorya pseudofischeri and its anamorph masquerading as Aspergillus fumigatus.

Authors:  S Arunmozhi Balajee; Jennifer Gribskov; Mary Brandt; James Ito; Annette Fothergill; Kieren A Marr
Journal:  J Clin Microbiol       Date:  2005-12       Impact factor: 5.948

Review 6.  Taxonomy and significance of black aspergilli.

Authors:  M Lourdes Abarca; Francesc Accensi; José Cano; F Javier Cabañes
Journal:  Antonie Van Leeuwenhoek       Date:  2004-07       Impact factor: 2.271

7.  Aspergillus section Fumigati: antifungal susceptibility patterns and sequence-based identification.

Authors:  Laura Alcazar-Fuoli; Emilia Mellado; Ana Alastruey-Izquierdo; Manuel Cuenca-Estrella; Juan L Rodriguez-Tudela
Journal:  Antimicrob Agents Chemother       Date:  2008-01-22       Impact factor: 5.191

8.  Head-to-head comparison of the activities of currently available antifungal agents against 3,378 Spanish clinical isolates of yeasts and filamentous fungi.

Authors:  Manuel Cuenca-Estrella; Alicia Gomez-Lopez; Emilia Mellado; Maria J Buitrago; Araceli Monzon; Juan Luis Rodriguez-Tudela
Journal:  Antimicrob Agents Chemother       Date:  2006-03       Impact factor: 5.191

9.  Polymerase chain reaction (PCR) identification of Aspergillus niger and Aspergillus tubingensis based on the calmodulin gene.

Authors:  A Susca; G Stea; G Mulè; G Perrone
Journal:  Food Addit Contam       Date:  2007-10

10.  In vitro susceptibilities of Aspergillus spp. causing otomycosis to amphotericin B, voriconazole and itraconazole.

Authors:  Ayse Demet Kaya; Nuri Kiraz
Journal:  Mycoses       Date:  2007-11       Impact factor: 4.377

View more
  30 in total

1.  Evaluation of Luminex xTAG fungal analyte-specific reagents for rapid identification of clinically relevant fungi.

Authors:  N Esther Babady; Edwin Miranda; Kathleen A Gilhuley
Journal:  J Clin Microbiol       Date:  2011-08-31       Impact factor: 5.948

2.  Identification of fungal isolates by MALDI-TOF mass spectrometry in veterinary practice: validation of a web application.

Authors:  Pierre Becker; Anne-Cécile Normand; Gerty Vanantwerpen; Mia Vanrobaeys; Roel Haesendonck; Francis Vercammen; Dirk Stubbe; Renaud Piarroux; Marijke Hendrickx
Journal:  J Vet Diagn Invest       Date:  2019-04-04       Impact factor: 1.279

3.  Wild-type MIC distributions and epidemiological cutoff values for the triazoles and six Aspergillus spp. for the CLSI broth microdilution method (M38-A2 document).

Authors:  A Espinel-Ingroff; D J Diekema; A Fothergill; E Johnson; T Pelaez; M A Pfaller; M G Rinaldi; E Canton; J Turnidge
Journal:  J Clin Microbiol       Date:  2010-06-30       Impact factor: 5.948

4.  Identification by Molecular Methods and Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry and Antifungal Susceptibility Profiles of Clinically Significant Rare Aspergillus Species in a Referral Chest Hospital in Delhi, India.

Authors:  Aradhana Masih; Pradeep K Singh; Shallu Kathuria; Kshitij Agarwal; Jacques F Meis; Anuradha Chowdhary
Journal:  J Clin Microbiol       Date:  2016-07-13       Impact factor: 5.948

5.  Species Distribution and In Vitro Azole Susceptibility of Aspergillus Section Nigri Isolates from Clinical and Environmental Settings.

Authors:  Roberta Iatta; Federica Nuccio; Davide Immediato; Adriana Mosca; Carmela De Carlo; Giuseppe Miragliotta; Antonio Parisi; Giuseppe Crescenzo; Domenico Otranto; Claudia Cafarchia
Journal:  J Clin Microbiol       Date:  2016-07-13       Impact factor: 5.948

6.  Molecular Identification and Susceptibility Testing of Molds Isolated in a Prospective Surveillance of Triazole Resistance in Spain (FILPOP2 Study).

Authors:  Ana Alastruey-Izquierdo; Laura Alcazar-Fuoli; Olga Rivero-Menéndez; Josefina Ayats; Carmen Castro; Julio García-Rodríguez; Lidia Goterris-Bonet; Elisa Ibáñez-Martínez; María José Linares-Sicilia; M Teresa Martin-Gomez; Estrella Martín-Mazuelos; Teresa Pelaez; Javier Peman; Antonio Rezusta; Susana Rojo; Rocio Tejero; Diego Vicente Anza; Jesús Viñuelas; Maria Soledad Zapico; Manuel Cuenca-Estrella
Journal:  Antimicrob Agents Chemother       Date:  2018-08-27       Impact factor: 5.191

7.  Species Identification and In Vitro Antifungal Susceptibility of Aspergillus terreus Species Complex Clinical Isolates from a French Multicenter Study.

Authors:  E Dannaoui; F Botterel; S Imbert; A C Normand; S Ranque; J M Costa; J Guitard; I Accoceberry; C Bonnal; A Fekkar; N Bourgeois; S Houzé; C Hennequin; R Piarroux
Journal:  Antimicrob Agents Chemother       Date:  2018-04-26       Impact factor: 5.191

8.  In Vitro Activities of Five Antifungal Drugs Against Opportunistic Agents of Aspergillus Nigri Complex.

Authors:  Hamid Badali; Hamed Fakhim; Fereshteh Zarei; Mojtaba Nabili; Afsane Vaezi; Nafiseh Poorzad; Somayeh Dolatabadi; Hossein Mirhendi
Journal:  Mycopathologia       Date:  2015-11-28       Impact factor: 2.574

9.  Multicenter study of isavuconazole MIC distributions and epidemiological cutoff values for Aspergillus spp. for the CLSI M38-A2 broth microdilution method.

Authors:  A Espinel-Ingroff; A Chowdhary; G M Gonzalez; C Lass-Flörl; E Martin-Mazuelos; J Meis; T Peláez; M A Pfaller; J Turnidge
Journal:  Antimicrob Agents Chemother       Date:  2013-05-28       Impact factor: 5.191

Review 10.  Multi-resistant aspergillosis due to cryptic species.

Authors:  Susan Julie Howard
Journal:  Mycopathologia       Date:  2014-06-27       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.